Panacea Biotec secures $8.9 million vaccine orders from UNICEF
pre-market1 source ↓written by the desknot a recommendation
- in additional orders
- $8.9 million
- 2026 now totals
- $16.8 million
- $2.55 million
- value increases
- $15.18 million
- adding
- $2.70 million
Panacea Biotec has expanded its vaccine order pipeline with UNICEF, securing $8.9 million in additional orders for the WHO pre-qualified pentavalent vaccine. The revised contract for 2026 now totals $16.8 million, up by $2.55 million, while the 2027 contract value increases to $15.18 million, adding $2.70 million. A new award for 2027 worth $3.68 million has also been secured.
Not investment advice. For informational purposes only.